Published in Blood Weekly, November 20th, 1995
PCR cannot be used in analyzing final plasma products for their safety in terms of hepatitis virus, if the products were manufactured by a process that includes virus inactivating methods, Dr. Joachim Hilfenhaus, Head of Virology, Research Laboratories of Behringwerke AG, Marburg, Germany stated.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.